Abstract
Plasma von Willebrand factor (vWf) displays a complex pattern of repeating multimers, whose heterogeneous size distribution seems to depend on the proteolytic cleavage of the constituent vWf subunit. Smaller vWf multimers are thought to derive by proteolytic cleavage of the larger forms. To clarify the relationship between large multimer representation and the structure of small vWf oligomers, DDAVP was infused in patients with type-2A and -2B von Willebrand disease (vWd) variants which lack circulating high vWf forms. Before infusion, high-resolution multimer analysis demonstrated a more pronounced representation of the satellite bands of each oligomer, mainly concerning fast-moving components, especially in type 2B vWd. After DDAVP, in type-2A vWd each oligomer displayed a different organization depending on whether restoration of large vWf multimers occurred. The lack of large vWf multimer restoration, as shown in citrated samples, was associated with the fast band being significantly more represented than the slower, and almost similar to the central component. In contrast, when the high-molecular-weight vWf forms were restored, as occurred in the samples collected in the presence of protease inhibitors, the relative representation of the fast- and slow-moving bands was similar to that of normal samples. In type-2B vWd, regardless of the anticoagulant used, DDAVP infusion did not restore large vWf multimers, and each oligomer displayed a significant increase in both the central band and fast-moving satellite, the fast being even more highly represented. These findings suggest that, regardless of the origin, the disappearance of large circulating multimers in type-2A and-2B vWd induces an increased representation of the fast-moving satellite of the low-molecular-weight multimers. Moreover, the time course of large and low/intermediate multimer decrease and increase provides a further demonstration that low vWf multimers derive from the larger ones, and that mainly the fast-moving band of the oligomer is involved.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ruggeri ZM, Zimmerman TS (1987) Von Willebrand factor and von Willebrand disease. Blood 70:895–904
Hoyer LW, Rissa CR, Tuddenham EGD, Carta CA, Armitage H, Rotblat F (1983) Von Willebrand factor multimeric patterns in von Willebrand disease. Br J Haematol 55:493–507
Ruggeri ZM, Zimmerman TS (1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140–1143
Ruggeri ZM, Zimmerman TS (1980) Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 65:1318–1324
Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS (1980) Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 302:1047–1051
De Marco L, Mazzuccato M, De Roia D, Casonato A, Federnici AB, Girolami A, Ruggeri ZM (1990) Distinct abnormalities in the interaction of purified IIA and IIB von Willebrand factor with the two platelet binding sites, glycoproteins Ib and IIb-IIIa. J Clin Invest 86:785–792
De Marco L, Mazzuccato M, Del Ben MG, Budde U, Federici AB, Girolami A, Ruggeri ZM (1987) Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin: role of platelet activation, fibrinogen and two distinct membrane receptors. J Clin Invest 80:475–482
Zimmerman TS, Dent, JA, Ruggeri ZM, Nannini NH (1986) Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual diformers (type IIC, IID and IIE). J Clin Invest 77:947–951
Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Nat Acad Scie USA 87:6306–6310
Dent JA, Galbusera M, Ruggeri ZM (1991) Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774–782
Berkowitz DS, Dent J, Roberts JR, Fujimura Y, Plow EE, Titani K, Ruggeri ZM, Zimmerman TS (1987) Epitope mapping of the von Willebrand factor subunits distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest 79:524–531
Gralnick HR, Williams SB, McKeown LP, Maisonneuve PH, Jenneau C, Sultan Y, Rick ME (1985) In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand's disease. Proc Natl Acad Sci USA 82:5968–5972
Battle J, Lopez-Fernandez MF, Campos M, Zimmerman TS (1986) The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood 68:1207–1212
Casonato A, Sartori MT, De Marco L, Girolami A (1990) 1-Desamino-8d arginin vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of variable pseudothrombocytopenia. Thromb Haemost 64:117–119
Casonato A, Fabris F, Vicariotto M, Girolami A (1985) The evaluation of factor VIII antigen by means of a simple slide test. Am J Clin Pathol 29:309–316
Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A (1970) A new congenital haemorrhagic condition due to the presence of normal factor X (factor X Friuli); study of a large kindred. Br J Haematol 19:179–192
Casonato A, De Marco L, Mazzuccato M, De Angelis V, De Ruia A, Fabris F, Ruggeri ZM, Girolami A (1989) A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor-platelet interaction and the presence of all von Willebrand factor multimers in plasma. Blood 74:2028–2033
Ciavarella G, Ciavarella N, Antonecchi S, De Mattia D, Ranieri P, Dent J, Zimmerman TS, Ruggeri ZM (1985) High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand's disease with aberrant structure but presence of all size multimers (IIC). Blood 66:1423–1429
Weiss HJ, Pietu G, Rabinowitz R, Girma J-P, Rogers J, Meyer D (1983) Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med 101:411–424
Lyons SE, Bruck ME, Bowie EJW, Ginsburg D (1992) Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 267:4424–4430
Furlan M, Robles R, Affolter D, Mayer D, Baillod P, Lammle B (1993) Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Thromb Haemost 69:2344
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Casonato, A., Pontara, E., Bertomoro, A. et al. Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors. Ann Hematol 71, 189–194 (1995). https://doi.org/10.1007/BF01910317
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01910317